Introduction {#s1}
============

The accumulation of mitochondrial DNA (mtDNA) with pathogenic mutations that induce defective mitochondrial respiration is a possible underlying cause of the development of mitochondrial diseases \[[@r25]\]. Previously, we generated mito-miceΔ (mice harbouring mtDNA with a large-scale deletion \[ΔmtDNA\]): the deletion was 4,696 bp long with a breaking point from nucleotide position 7,759 in the *mt-Tk* gene to 12,454 in the *mt-Nd5* gene, and it included 6 tRNA genes and 7 structural genes \[[@r11]\]. Then, we showed that these mice developed phenotypes of mitochondrial diseases only when ΔmtDNA had accumulated predominantly to reduce mitochondrial respiratory function \[[@r11], [@r19]\]. These results provided direct evidence indicating that mitochondrial diseases are the result of defective mitochondrial respiration caused by the accumulation of mtDNA with a pathogenic mutation.

Because small amounts of mtDNA with the same pathogenic mutations as those found in patients with mitochondrial diseases accumulate in the tissues of normal elderly humans, the mitochondrial theory of aging \[[@r13], [@r14], [@r23], [@r25]\] proposes that accumulation of mtDNA with pathogenic mutations is responsible not only for the development of mitochondrial diseases but also for the development of human aging and age-associated disorders. This hypothesis is supported by mtDNA mutator mice, which are generated by the introduction of a proofreading-deficient mtDNA polymerase gene \[[@r2], [@r16], [@r24]\]; during mtDNA replication in these mice, defective proofreading results in accelerated accumulation of somatic mutations in their mtDNA with aging and simultaneous development of early onset defective mitochondrial respiration and premature aging phenotypes.

In contrast, mito-miceΔ show accelerated accumulation of ΔmtDNA with age due to its smaller size compared with wild-type mtDNA and simultaneously express early onset defective mitochondrial respiration and phenotypes related to mitochondrial diseases but do not express premature aging phenotypes \[[@r11], [@r19]\]. So why premature aging phenotypes are observed in mtDNA mutator mice but not in mito-miceΔ even though both model mice develop age-associated defective mitochondrial respiration is an issue that has not yet been resolved.

Previously \[[@r18]\], we reported that one possible reason behind the exclusive development of premature aging phenotypes in mtDNA mutator mice could be the differences in the nuclear genetic background used to generate these model mice. That is, when mtDNA mutator mice shared the same nuclear genetic background as mito-miceΔ, i.e., C57BL/6J (hereafter referred to as B6J), both models developed kyphosis but not alopecia or hair graying \[[@r18]\], which have been reported to develop in mtDNA mutator mice as premature aging phenotypes \[[@r16], [@r24]\]. Indeed, differences in nuclear genetic background have also been shown to affect phenotypic spectrum even in inbred mice \[[@r5], [@r6], [@r8], [@r15]\].

Because most human kyphosis is caused by osteoporosis \[[@r20]\], previously we examined trabecular and cortical bone thickness and found decreased cortical bone thickness in mito-miceΔ and mtDNA mutator mice but not in aged mice \[[@r17]\]. Moreover, human age-associated osteoporosis is frequently characterized by decreased trabecular bone thickness without decreased cortical bone thickness \[[@r20]\]. This suggests that decreased cortical bone thickness is not associated with aging in either mice or humans. In contrast, decreased cortical bone thickness together with osteoporosis, which we reported in mito-miceΔ and mtDNA mutator mice \[[@r17]\], is seen in patients with hyperparathyroidism, which is caused by excessive secretion of parathyroid hormone (PTH) from the parathyroid glands in response to hypocalcaemia \[[@r4]\].

Therefore, this study examined whether mito-miceΔ and mtDNA mutator mice can be used as models of human osteoporosis caused by aging or hyperparathyroidism.

Materials and Methods {#s2}
=====================

Mice
----

Inbred B6J male mice generated by sibling mating more than 40 times were obtained from CLEA Japan (Tokyo, Japan). Mito-miceΔ \[[@r11]\] and mtDNA mutator mice \[[@r18]\] sharing the B6J nuclear genetic background were generated as reported previously. We used 10-month-old mito-miceΔ with 81.2 ± 1.3% ΔmtDNA in their tails and 10-month-old mtDNA mutator mice homozygous for the mtDNA polymerase editing mutation, PolgD257A, because these mice had osteoporosis \[[@r17]\] corresponding to a phenotype prevalently observed in elderly human subjects. The proportion of ∆mtDNA in their tissues was deduced by its estimation using the tails, because it did not differ significantly among different tissues from the same mito-mice∆ \[[@r11]\]. The proportion of ΔmtDNA in their tails was determined by means of real-time polymerase chain reaction analysis, as described previously \[[@r21]\]. With respect to the mutations in mtDNA mutator mice, sequence analysis revealed that 22 point mutations were accumulated in fifty clones of 517 bp-fragments of the *mt-Co1* gene in the mtDNA prepared from the heart of an mtDNA mutator mouse (10 months old), while no mutations were found in the heart of an age-matched B6J mouse \[[@r18]\]. We also used 10-month-old B6J mice and 27-month-old B6J mice as age-matched controls and aged mice, respectively. Animal experiments were performed in accordance with protocols approved by the Experimental Animal Committee of the University of Tsukuba, Japan.

Measurement of serum PTH and Ca^2+^ concentrations
--------------------------------------------------

Serum PTH concentrations were measured by using a mouse PTH 1-84 ELISA Kit (Immutopics, Inc., Athens, OH, USA). Serum Ca^2+^ concentrations were measured by using the o-cresolphthalein complexone method (Nescoat Ca-V2, Alfresa, Tokyo, Japan).

Histological analyses
---------------------

Paraffin-embedded sections of decalcified femurs were subjected to tartrate-resistant acid phosphatase (TRAP) staining by using a TRAP/ALP staining kit (Wako Pure Chemical Industries, Osaka, Japan). The percentage of bone surface covered with osteoclasts was calculated from TRAP-stained sections by using the Leica Application Suite V4.5 software (Leica, Wetzlar, Hesse, Germany). Histochemical analyses for COX and succinate dehydrogenase activities were performed as described previously \[[@r18]\] by using cryosections (thickness, 10 *µ*m) of renal or duodenal tissue. Haematoxylin and eosin--stained sections were used for histopathological analysis of renal tissue.

Measurement of blood urea nitrogen (BUN)
----------------------------------------

Blood samples were collected via the retro-orbital vein. BUN concentrations were determined by using a Urea NB test kit (Wako Pure Chemical Industries).

Statistical analysis
--------------------

Data were analysed by using Dunnett's test or one-way ANOVA followed by Dunnett's post hoc test. *P*\<0.05 was considered statistically significant.

Results {#s3}
=======

First, we determined the serum concentrations of PTH, and we found a significantly higher serum PTH concentration both in mito-miceΔ and mtDNA mutator mice (10 months old) compared with age-matched control B6J mice (10 months old; *P*\<0.05) or aged B6J mice (27 months old; *P*\<0.05) ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Comparison of serum parathyroid hormone (PTH) levels between age-matched control mice (Control; 10-month-old mice as age-matched controls), aged mice (Aged; 27-month-old mice), mito-miceΔ (Delta; 10-month-old mito-miceΔ), and mtDNA mutator mice (Mutator; 10-month-old mtDNA mutator mice). The amount of ΔmtDNA in the tail of the mito-miceΔ was 81.2 ± 1.3%. Data are presented as the mean + SD. \**P*\<0.05 (n=3).).

Excessive secretion of PTH enhances bone resorption via osteoclast activation, resulting in decreased cortical bone thickness and osteoporosis \[[@r4]\]. Therefore, next we estimated the percentage of cortical bone and trabecular bone covered by osteoclasts in histological sections of femur. In mito-miceΔ and mtDNA mutator mice, the percentage of the surface of cortical bone ([Fig. 2A](#fig_002){ref-type="fig"}Fig. 2.Histopathological analysis of osteoclast coverage of the surface of cortical bone (A) and trabecular bone (B) after tartrate-resistant acid phosphatase (TRAP) staining in age-matched control mice (Control; 10-month-old mice as age-matched controls), aged mice (Aged; 27-month-old mice), mito-miceΔ (Delta; 10-month-old mito-miceΔ), and mtDNA mutator mice (Mutator; 10-month-old mtDNA mutator mice). The amount of ΔmtDNA in the tail of the mito-miceΔ was 81.2 ± 1.3%. Upper panels: Histological analysis. Red arrowheads indicate osteoclasts (OCs) stained red with TRAP. Lower panels: Percentage of bone surface covered with OCs. The percentage of the bone surface covered with OCs was determined from the histological sections shown in the upper panels by using the Leica Application Suite V4.5 software (Leica, Wetzlar, Hesse, Germany). Data are presented as the mean + SD. \**P*\<0.05 (n=3). Scale bars, 50 *µ*m.), but not trabecular bone ([Fig. 2B](#fig_002){ref-type="fig"}), covered by osteoclasts was significantly larger than that of age-matched control B6J mice (10 months old; *P*\<0.05), suggesting that mito-miceΔ and mtDNA mutator mice develop pathological features that are similar to those seen in human hyperparathyroidism \[[@r4]\]. In addition, significantly less cortical bone ([Fig. 2A](#fig_002){ref-type="fig"}) and trabecular bone ([Fig. 2B](#fig_002){ref-type="fig"}) surface was covered by osteoclasts in aged 27-month-old B6J mice than in 10-month-old control B6J mice (*P*\<0.05), which is consistent with previous observations reported in aged humans \[[@r1]\].

Patients with hyperparathyroidism also have elevated serum concentrations of circulating ionized calcium (Ca^2+^) (i.e., hypercalcaemia) due to increased cortical bone resorption \[[@r4]\]. Therefore, we determined the serum concentrations of Ca^2+^ and found significantly higher concentrations of Ca^2+^ in mito-miceΔ and mtDNA mutator mice but not in aged B6J mice compared with control B6J mice (*P*\<0.05; [Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Serum circulating ionized calcium (Ca^2+^) levels in age-matched control mice (Control; 10-month-old mice as age-matched controls), aged mice (Aged; 27-month-old mice), mito-miceΔ (Delta; 10-month-old mito-miceΔ), and mtDNA mutator mice (Mutator; 10-month-old mtDNA mutator mice). The amount of ΔmtDNA in the tail of the mito-miceΔ was 81.2 ± 1.3%. Data are presented as the mean + SD. \**P*\<0.05 (n=3).).

Together, these observations suggest that in mito-miceΔ and mtDNA mutator mice, increased serum concentrations of PTH ([Fig. 1](#fig_001){ref-type="fig"}) causes increased recruitment of osteoclasts to the surface of cortical bone ([Fig. 2A](#fig_002){ref-type="fig"}), which results in increased bone resorption leading to increased serum concentrations of Ca^2+^ (hypercalcaemia; [Fig. 3](#fig_003){ref-type="fig"}) and decreased cortical bone thickness (osteoporosis) \[[@r17]\].

Next, we examined why the serum concentration of PTH was higher in mito-miceΔ and mtDNA mutator mice than in age-matched control mice and aged mice ([Fig. 1](#fig_001){ref-type="fig"}). In patients with hyperparathyroidism, impaired renal tubular reabsorption of Ca^2+^ from urine or impaired duodenal absorption of Ca^2+^ from food leads to hypocalcaemia and increased secretion of PTH in response to hypocalcaemia \[[@r4]\]. Thus, we hypothesized that defective mitochondrial respiration in the kidney and duodenum in mito-miceΔ and mtDNA mutator mice, respectively, causes hypocalcaemia leading to increased secretion of PTH.

Anaemia and a granulated surface of the kidney were exclusively observed in mito-miceΔ ([Fig. 4A](#fig_004){ref-type="fig"}Fig. 4.Macroscopic and histopathological analyses of the kidney and duodenum of age-matched control mice (Control; 10-month-old mice as age-matched controls), aged mice (Aged; 27-month-old mice), mito-miceΔ (Delta; 10-month-old mito-miceΔ), or mtDNA mutator mice (Mutator; 10-month-old mtDNA mutator mice). The amount of ΔmtDNA in the tail of the mito-miceΔ was 81.2 ± 1.3%. (A) Abnormalities of the kidney. Macroscopy: Macroscopic view showing anaemia and the granulated surface of a representative mito-miceΔ kidney. Scale bar, 1 cm. COX/SDH: Tissue sections were stained for cytochrome c oxidase (COX) and succinate dehydrogenase (SDH). COX and SDH activities were detected as a brown and blue colours, respectively. Because mtDNA encodes three subunits of COX and no subunits of SDH, mutations in mtDNA reduced COX but not SDH activity. Therefore, tissues with reduced COX activity appear to contain more blue regions. COX/SDH staining revealed the presence of defective mitochondrial respiration in mito-miceΔ and mtDNA mutator mice but not in aged mice. Scale bar, 100 *µ*m. HE: Haematoxylin and eosin (HE) staining revealed the presence of renal tubules with dilated lumens and casts (arrowhead) in mito-miceΔ. Scale bar, 100 *µ*m. Increased blood urea nitrogen (BUN) levels were also found in mito-miceΔ. Data are presented as the mean + SD. \**P*\<0.05 (n=3). (B) Abnormalities of duodenum. COX/SDH staining revealed defective mitochondrial respiration in mito-miceΔ and mtDNA mutator mice but not in aged mice., upper). Then, we conducted a histochemical analysis of mitochondrial respiration in the kidneys of mito-miceΔ and mtDNA mutator mice and found that a significant reduction in cytochrome c oxidase (COX) activity was observed in mito-miceΔ ([Fig. 4A](#fig_004){ref-type="fig"}, middle). A histopathological analysis of the kidney also revealed renal tubules with dilated lumens and casts in mito-miceΔ ([Fig. 4A](#fig_004){ref-type="fig"}, lower). Moreover, a significantly higher serum concentration of BUN (*P*\<0.05), which is a marker of renal failure, was observed in mito-miceΔ compared with mtDNA mutator mice, age-matched control mice, and aged mice (*P*\<0.05; [Fig. 4A](#fig_004){ref-type="fig"}, graph). The development of renal failure in mito-miceΔ but not in mtDNA mutator mice ([Fig. 4A](#fig_004){ref-type="fig"}) is consistent with our previous observations \[[@r18]\], although the reasons why renal failure exclusively develops in mito-miceΔ remain unknown.

It has also been suggested that mtDNA mutator mice develop markedly defective mitochondrial respiration in the duodenum \[[@r3]\]. Our histochemical analysis also revealed a significant reduction in COX activity in the duodenum of mtDNA mutator mice ([Fig. 4B](#fig_004){ref-type="fig"}). The absence of an age-associated decline in mitochondrial respiration in aged mice with the B6J nuclear background ([Fig. 4](#fig_004){ref-type="fig"}) is consistent with the results of our previous study \[[@r22]\].

It is likely that the preferential expression of the respiration defects in the kidney of mito-mice∆ and in the duodenum of mtDNA mutator mice are due partly to a slightly higher accumulation of ∆mtDNA in the kidney of mito-mice∆ \[[@r11]\] and a slightly higher accumulation of somatic mtDNA mutations in the duodenum of mtDNA mutator mice \[[@r16]\]. Because renal tubules and the duodenum are important for Ca^2+^ reabsorption and Ca^2+^ absorption, respectively, defective mitochondrial respiration in the kidney and/or duodenum ([Fig. 4](#fig_004){ref-type="fig"}) would result in reduced serum concentrations of Ca^2+^ (hypocalcaemia). However, we are unable to explain the exact mechanisms of how respiration defects induce impaired Ca^2+^ reabsorption in the kidney and impaired Ca^2+^ absorption in the duodenum. Hypocalcaemia causes increased secretion of PTH, and the resultant high serum concentration of PTH ([Fig. 1](#fig_001){ref-type="fig"}) induces bone reabsorption to compensate for the hypocalcaemia via activating osteoclasts ([Fig. 2A](#fig_002){ref-type="fig"}), leading to hypercalcaemia ([Fig. 3](#fig_003){ref-type="fig"}), decreased cortical bone thickness \[[@r17]\], and osteoporosis \[[@r4]\].

Considering that the aged mice developed neither defective mitochondrial respiration ([Fig. 4](#fig_004){ref-type="fig"}) nor increased serum concentrations of PTH ([Fig. 1](#fig_001){ref-type="fig"}), we conclude that osteoporosis in mito-miceΔ and mtDNA mutator mice develops via respiration defects and hyperparathyroidism but not via aging ([Supplementary Fig. S1](#pdf_001){ref-type="supplementary-material"}).

Discussion {#s4}
==========

In the present study, we precisely examined the development of osteoporosis, one of the premature aging phenotypes observed in mtDNA mutator mice \[[@r16], [@r24]\], for three reasons. First, age-associated kyphosis caused by osteoporosis is the only premature aging phenotype observed in mtDNA mutator mice with the B6J nuclear genetic background \[[@r18]\]. Second, development of osteoporosis due to decreased cortical bone thickness has been shown in mito-miceΔ and mtDNA mutator mice \[[@r17]\] but not in aged mice \[[@r17]\] or aged humans \[[@r20]\]. Third, decreased cortical bone thickness has been reported in patients with hyperparathyroidism \[[@r4]\].

To examine whether or not mito-miceΔ and mtDNA mutator mice could be useful models of human osteoporosis associated with hyperparathyroidism rather than human aging, we determined the serum concentrations of PTH and found higher concentrations in mito-miceΔ and mtDNA mutator mice than in aged mice ([Fig. 1](#fig_001){ref-type="fig"}). In addition, a histopathological analysis revealed reduced mitochondrial respiration in the kidney ([Fig. 4A](#fig_004){ref-type="fig"}) and duodenum ([Fig. 4B](#fig_004){ref-type="fig"}) in mito-miceΔ and mtDNA mutator mice. This suggests that impaired Ca^2+^ reabsorption from urine via the renal tubules or impaired Ca^2+^ absorption from food via the duodenum due to defective mitochondrial respiration leads to hypocalcaemia, which in turn stimulates excessive secretion of PTH from the parathyroid glands ([Supplementary Fig. S1](#pdf_001){ref-type="supplementary-material"}).

We also found that mito-miceΔ and mtDNA mutator mice not only have defective mitochondrial respiration and high serum concentrations of PTH but also increased recruitment of osteoclasts to the cortical bone surface ([Fig. 2A](#fig_002){ref-type="fig"}), which results in decreased cortical bone thickness and hypercalcaemia ([Fig. 3](#fig_003){ref-type="fig"}). Although decreased cortical bone thickness was not observed in aged mice \[[@r17]\] and in aged human subjects \[[@r20]\], this phenotype has been reported in humans with hyperparathyroidism \[[@r4]\]. This suggests that mito-miceΔ and mtDNA mutator mice may be useful models for investigating the pathogenesis of the osteoporosis that develops in humans in association with hyperparathyroidism rather than age ([Supplementary Fig. S1](#pdf_001){ref-type="supplementary-material"}).

The mitochondrial theory of aging proposes that human aging is caused by accumulation of somatic mutations in mtDNA leading to defective mitochondrial respiration \[[@r13], [@r14], [@r23], [@r25]\]. However, we recently reported that the age-associated respiration defects in elderly human fibroblasts could be restored by reprogramming them (isolation of induced pluripotent stem cells \[iPSCs\] from fibroblast and redifferentiation of them into fibroblasts) \[[@r7], [@r10]\]. Therefore we proposed an alternative theory that human fibroblasts isolated from elderly subjects develop defective mitochondrial respiration not due to mutations in their mtDNA \[[@r7], [@r9], [@r12]\] but due to epigenetic downregulation of nuclear-encoded genes \[[@r7], [@r10]\].

In contrast, the mitochondrial theory of aging is supported by the creation of mtDNA mutator mice because of their increased accumulation of somatic mutations in mtDNA and consequent development of defective mitochondrial respiration and premature aging phenotypes \[[@r2], [@r16], [@r24]\]. However, the present study revealed that the mechanism underlying the development of osteoporosis, which corresponds to the only premature aging phenotype observed in mtDNA mutator mice with the B6J nuclear genetic background \[[@r18]\], is fundamentally different from the mechanism underlying the development of osteoporosis in aged mice or aged humans. Therefore, the phenotypes observed in mtDNA mutator mice do not necessarily support the concept that accumulation of mtDNA with pathogenic mutations is responsible for the development of aging phenotypes.
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